The caller, patient's wife, alleged a variance between the inratio inr result in comparison to the poc inr results.The results were as follows: (b)(6) inratio inr=3.0.(b)(6) alternate poc inr=5.9, repeat 6.1.The patient self tester's therapeutic range is: 2.0-3.0.Other information provided by the patient self tester's wife, (b)(6): (b)(6) patient self tester (pst) injured leg on car door which created a hematoma.Pst taking antibiotics and pain medication.(b)(6) thinks last dose of antibiotics was week of (b)(6) however, cannot confirm.(b)(6) inratio = 3.0.(b)(6) pst given normal warfarin dose (6mg/day).(b)(6) and (b)(6) - withheld warfarin due to scheduled surgery.(b)(6) (b)(6) hospital - alternate poc = 5.9, repeat 6.1 (5 minutes, different hand).(b)(6) drs office alternate poc = 5.9 (b)(6) withheld warfarin due to alternate poc result.(b)(6) cataract surgery delayed due to inr result.No additional inratio results.(b)(6) pst admitted to hospital due to exacerbation of injury on leg.(b)(6) withheld warfarin dose.Inr in hospital.Dates and results unknown.(b)(6) hospital inr lab = 1.9 warfarin dose=5mg/day.(b)(6) warfarin dose=5mg/day.(b)(6) pst relocated to nursing home for care due to infection in wound.Pst started antibiotics.No inratio testing during this time.
|
Conclusion: it is indicated that product is not returning for evaluation.Therefore, a review in-house testing was performed.In-house strip testing on the reported strip lot had met criteria.The product performed as expected.Although relevant non-conformances were noted in the batch record, they did not affect the final release specifications.There is no indication of a product deficiency and additional corrective actions were not required.Although improper techniques were identified in the complaint, root cause cannot be determined from the information provided.Based on the information available, there is no indication of a product deficiency.No corrective action is required at this time.
|